Bio Solution Co.,Ltd. Logo

Bio Solution Co.,Ltd.

Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.

086820 | KO

Overview

Corporate Details

ISIN(s):
KR7086820008
LEI:
Country:
South Korea
Address:
서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on the provided sources, Bio Solution Co., Ltd. is a biotechnology and life sciences company, not a financial data provider. The company develops, manufactures, and sells cell therapy products for degenerative diseases. Its offerings include CartiLife, an autologous chondrocyte cell-based therapy. Additionally, the company produces and supplies a range of bio-laboratory reagents and kits for research and development purposes. These products are used in applications such as yeast two-hybrid assays, nucleic acid precipitation, and protein and DNA electrophoresis. The company is ISO 13485:2016 certified, indicating adherence to quality management standards for medical devices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승…
Korean 8.9 KB
2025-08-25 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-01 00:00
Related Party Transaction
금전대여결정
Korean 19.4 KB
2025-06-05 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-05 00:00
Legal Proceedings Report
투자판단관련주요경영사항 (펠렛형 동종 연골세포치료제(카티로이드)의 제1/2상 임상시험계획 승인신청 반려)
Korean 8.8 KB
2025-05-30 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-05-29 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 27.7 KB
2025-05-26 00:00
Share Issue/Capital Change
권리락 (무상증자)
Korean 3.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 880.1 KB
2025-05-13 00:00
Share Issue/Capital Change
주권매매거래정지 (무상증자)
Korean 4.8 KB
2025-05-13 00:00
Share Issue/Capital Change
주요사항보고서(무상증자결정)
Korean 12.0 KB
2025-05-13 00:00
Share Issue/Capital Change
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-05-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB

Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bio Solution Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.